31 semi-structured interviews conducted between May and July 2025 with India-based experts in pharmaceutical development, manufacturing, procurement, and regulation. The dataset likely contains coded responses examining tiered manufacturing as a commercial determinant of health. The data was authored by Jean Christophe Rusatira and published on figshare in June 2026.
Use Cases
- Analyzing perceptions of tiered manufacturing practices based on expert interview transcripts.
- Mapping commercial drivers of pharmaceutical quality disparities based on respondent descriptions.
- Evaluating proposed regulatory solutions like WHO prequalification reliance based on interview themes.
Strengths
- 31 expert interviews provide qualitative depth.
- Data collection spanned May to July 2025, offering a defined time frame.
- Purposive sampling ensured variation in geography, organizational type, and role.
Limitations
- Row count is unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- The 5.5 KB file size suggests a very limited scope of data.
Provenance
- Source
- figshare
- Collection Method
- Semi-structured interviews, coded deductively using CDoH domains and inductively for emergent themes.
- Time Range
- May to July 2025
- Freshness
- Last updated 2026-06-03 17:37:04; freshness should be verified.
- Geography
- Primarily India-based experts